Apis Capital Advisors, LLC Global Blood Therapeutics, Inc. Transaction History

Apis Capital Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$37.65 - $63.77 $941,250 - $1.59 Million	-25,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$45.35 - $57.91 $226,750 - $289,550	5,000 Added 25.0%	25,000 $1.21 Million
Q2 2019 Aug 13, 2019	SELL	$52.6 - $63.29 $263,000 - $316,450	-5,000 Reduced 20.0%	20,000 $1.05 Million
Q1 2019 May 07, 2019	SELL	$39.99 - $53.48 $79,980 - $106,960	-2,000 Reduced 7.41%	25,000 $1.32 Million
Q4 2018 Feb 14, 2019	BUY	$31.54 - $46.67 $851,580 - $1.26 Million	27,000 New	27,000 $1.11 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Apis Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Apis Capital Advisors, LLC with notifications on news.